Ending TB Through Expertise and Action

Tuberculosis (TB) is a preventable and curable disease. But it’s the deadliest infectious disease globally and every year, far too many children lose their lives to it. Children and adolescents suffer uniquely: their symptoms are harder to detect, their access to diagnosis and treatment is limited, and the stakes are high.

At EGPAF, our work to end pediatric HIV naturally extends to TB. By integrating TB prevention, testing, and treatment into our HIV programs, we ensure that children get the care they need. No child should have to fight one life-threatening disease while at risk for another. Together, we can protect children, support families, and move closer to a generation free from both HIV and TB.

Get the Facts

In 2023, 1.25 million children aged 0-14 years old fell ill with TB around the world.
Globally, an estimated 52% of children under 5 with TB go undiagnosed, untreated or unreported.
An estimated 33% of deaths among children living with HIV are due to TB.

EGPAF’s Strategy: Prioritize Children & Adolescents in Every TB Response

EGPAF has experience embedding TB prevention, testing, and treatment into HIV service delivery (via PEPFAR support), because the overlap is too large to ignore. Our goals:

Drive innovations that detect disease faster, treat it more effectively, and broaden access to preventive care for kids and teens.
Use lessons from projects like CaP-TB (Unitaid) and our participation in the SMART4TB Consortium to scale what works.

Key Areas of Focus

Finding the Missing Cases

Children under 5 are routinely underdiagnosed. Existing tools often require invasive sampling or miss subtle signs of TB. EGPAF scales up child-friendly screening and diagnostics in clinics and communities to close the detection gap.

Preventive Treatment (TPT) Expansion

New, shorter regimens are available — but uptake is still far below what’s needed. Ensuring all eligible children in TB-affected households receive TPT (with pediatric formulations) is essential to stop disease before it starts.

Child-Friendly Treatment Regimens

When treatment is available but hard to use (bitter medicines, complicated dosage, long courses), outcomes suffer. EGPAF advocates for shorter, easier, child-suitable treatment regimens, both for drug-susceptible and drug-resistant TB.

Models of Care Designed for Children and Families

Children need services that are accessible, integrated into routine health care, and delivered where they are: at primary health centers, in community settings. Integrating TB care into maternal, child, and adolescent health services helps catch disease earlier, reduce severe illness, and improve survival.

Advocating for Investment in the TB Response

Significant increases in both international and domestic resources are needed to sufficiently scale up childhood TB services and end the global TB epidemic. By 2027, $22 billion is needed annually for TB prevention, diagnosis, treatment and care across all populations.

What the Data Tells Us: The Urgent Gaps

Of the children who died from TB in 2023, nearly all had no access to treatment
Drug-resistant TB in children remains grossly under-reported and under-treated.
Preventive treatment among young children (contacts under age 5) remains too low — just around one-third or less are reached.

The Way Forward & EGPAF’s Promise

With better tools, stronger commitment, and smart investments, we can dramatically reduce deaths, prevent illness, and ensure every child has the chance to grow up healthy. EGPAF stands with children, families, health workers, and communities. We will not rest until pediatric TB is a disease of the past.